The nuclear receptor coactivator RAC3 inhibits autophagy

FERNANDEZ LARROSA PN; ALVARADO CV; RUBIO MF; RUIZ GRECCO M; MICENMACHER S; MARTINEZ-NOEL GA; PANELO L; COSTAS MA

CANCER SCIENCE

WILEY-BLACKWELL PUBLISHING, INC

Lugar: Londres; Año: 2012 vol. 103 p. 2064 - 2071

1347-9032

RAC3 is an oncogene naturally overexpressed in several tumors. Besides its role as coactivator, it can exert several protumoral cytoplasmic actions. Autophagy was found to act either as a tumor suppressor during the early stages of tumor development, or as a protector of the tumor cell in later stages under hypoxic conditions. We found that RAC3 overexpression inhibits autophagy when induced by starvation or rapamycin and involves RAC3 nuclear translocation-dependent and -independent mechanisms. Moreover, hypoxia inhibits the RAC3 gene expression leading to the autophagy process, allowing tumor cells to survive until angiogenesis occurs. The interplay between RAC3, hypoxia, and autophagy could be an important mechanism for tumor progression and a good target for a future anticancer therapy.